Compound 706
Identifiers
- Canonical SMILES:
CC(=O)N1[C@H](CC(C)(C)C)[C@@]2([C@H]([C@@H]1C(=O)NCC[C@H](O)CO)c1ccc(F)c(Cl)c1)C(=O)Nc1cc(Cl)c(F)cc21
- IUPAC name:
(2'R,3S,3'R,5'R)-1'-acetyl-6-chloro-3'-(3-chloro-4-fluorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-5-fluoro-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C29H33Cl2F2N3O5/c1-14(38)36-23(12-28(2,3)4)29(17-10-21(33)19(31)11-22(17)35-27(29)41)24(15-5-6-20(32)18(30)9-15)25(36)26(40)34-8-7-16(39)13-37/h5-6,9-11,16,23-25,37,39H,7-8,12-13H2,1-4H3,(H,34,40)(H,35,41)/t16-,23+,24-,25+,29-/m0/s1
- InChiKey:
UEVULXUOMVMHDC-CWEXNXMASA-N
External links
25000117 |
External search
Bibliography (1)
Publication | Name |
---|---|
Shaomeng Wang, Dongguang Qin, Jianyong Chen, Shanghai Yu, The Regents Of The University Of Michigan. . New small molecule inhibitors of mdm2 and the uses thereof None. | 319-13 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 3 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.49 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 611.18 g/mol | |||
HBA | 8 | |||
HBD | 4 | |||
HBA + HBD | 12 | |||
AlogP | 3.16 | |||
TPSA | 118.97 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 3 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2008036168 | 319-13 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.23 | |
WO2008036168 | 319-13 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | LNCaP cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.44 |
WO2008036168 | 319-13 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | HCT-116 cells p53WT | pIC50 (half maximal inhibitory concentration, -log10) | 5.49 |
WO2008036168 | 319-13 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | PC-3 cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.76 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8261 | SAR-405838 | DB12541 | |
0.6579 | Milademetan | DB15257 | |
0.5566 | Degarelix | DB06699 | |
0.5314 | Abarelix | DB00106 | |
0.5303 | SLV-334 | DB15356 | |
0.5220 | Acyline | DB11906 | |
0.5181 | Brimapitide | DB15231 | |
0.5147 | Daglutril | DB05796 | |
0.5094 | Tifuvirtide | DB05413 | |
0.5077 | Mosapramine | DB13676 | |
0.5064 | MK-3207 | DB12424 | |
0.5029 | Difelikefalin | DB11938 | |
0.5025 | Bivalirudin | DB00006 | |
0.5021 | Daptomycin | DB00080 | |
0.5000 | Polymyxin B | DB00781 |